mechanism of action of glp-1 receptor agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Nephroprotective effects of GLP-1 receptor

In addition, the optimal conditions for entraining the electrical pacesetters that control gastric motor function are still being developed, and it is possible that advances in electrical stimulation may ultimately achieve the clinical promise that has been a goal for at least three decades

Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, et al

GLP-1RAs not only have the potential to treat the above-mentioned diseases but also ameliorate the co-morbidities simultaneously, which is important for patients with autoimmune/autoinflammatory diseases combined with metabolic diseases

When blood glucose (BG) concentrations are normal or high, the intestines secrete GLP-1 and GIP to act on pancreatic beta cells through intracellular signaling pathways that involve cyclic adenosine monophosphate (cAMP)

Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, et al